Strategic Analysis of the ADME/TOX Technologies Market in Europe

1 STRATEGIC ANALYSIS OF THE ADME/TOX TECHNOLOGIES MARKET IN EUROPE

Overview

Overview

Research Scope and Methodology

Research Scope and Methodology

Introduction and Background

Introduction and Background

Key Definitions and Abbreviations

Exchange Rates

Background and Drug Discovery Processes

Successful Drug Candidates

Secondary Screening

Failure of Lead Candidates

ADME/Toxicity Testing

Role of ADME Studies for Drug Discovery

Global ADME/Tox Screening Market Revenue

Therapeutic Efficacy and Toxicity

Drug-like Properties for ADME/TOX Studies

ADME/Tox Profiles I-II

Market Dynamics

Market and Technology Trends I & II

Industry Challenges

Using ADME/Tox to Overcome Challenges

Market Drivers

Market Restraints

Market Status and Size

Total Market Forecasts

Assumptions

Key Market Engineering Measurements

EU ADME/TOX Market Revenue Forecasts

EU ADME/TOX Market Revenue Analysis

Segmentation of ADME/TOX Market

Segmentation Revenue Forecasts

Segmentation Revenue Analysis

Company Profiles

Strategic Analysis and Recommendations

Major Challenges and Strategies

Summary of Strategic Proposals

Quotes

Market Maturation Process

Strategic Anticipation

Potential Threats

Competitive Framework

Market Potential

Three Levels Of Strategies

Pricing Strategy

Meeting the Challenge

Frost & Sullivan Awards

Frost & Sullivan Awards

Product Innovation Award

Customer Service Innovation Award

Growth Strategy Leadership Award

Market Penetration Leadership Award

Industry Participants

Industry Participants

Decision Support Databases

Decision Support Databases

Frost & Sullivan

Healthcare Team

Our Capabilities